Day: July 24, 2024

Next Generation Sequencing Market to Witness 18.5% CAGR by 2031 | SkyQuest Technology

Westford,USA, July 24, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Next Generation Sequencing Market will attain a value of USD 36.04 billion by 2031, with a CAGR of 18.5% during the forecast period (2024-2031). Next generation sequencing is a technique that uses high similarity to align millions or even billions of strands of DNA. This method is also known as high throughput sequencing. NGS does not rely heavily on the fragment replication techniques used by Sanger in genome sequencing. Advantages of NGS over Sanger’s sequencing method include low cost, high accuracy and speed, and accurate results even if small sample sizes are used. Thus, NGS is widely used for biomarker discovery, cancer in research, personalized medicine and farm animal research. Download a detailed overview:https://www.skyquestt.com/sample-request/next-generation-sequencing-market...

Continue reading

HomeTrust Bancshares, Inc. Announces Financial Results for the Second Quarter of the Year Ending December 31, 2024 and Declaration of a Quarterly Dividend

ASHEVILLE, N.C., July 24, 2024 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company” or “HomeTrust”), the holding company of HomeTrust Bank (“Bank”), today announced preliminary net income for the second quarter of the year ending December 31, 2024 and approval of its quarterly cash dividend. For the quarter ended June 30, 2024 compared to the quarter ended March 31, 2024: net income was $12.4 million compared to $15.1 million; diluted earnings per share (“EPS”) were $0.73 compared to $0.88; annualized return on assets (“ROA”) was 1.13% compared to 1.37%; annualized return on equity (“ROE”) was 9.58% compared to 11.91%; net interest margin was 4.08% compared to 4.02%; provision for credit losses was $4.3 million compared to $1.2 million; tax-free...

Continue reading

Primech Holdings Reports 5.1% Increase in Revenue, $144.4 Million in Future Contracted Revenues Guidance

SINGAPORE, July 24, 2024 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company”), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, today announces its financial results for fiscal year ended March 31, 2024. Mr. Kin Wai Ho, Chief Executive Officer of Primech, commented, “Primech is pleased to report strong financial results in our first year as a public company, with increased revenues for fiscal year 2024. Our future looks very promising; we have amassed $144.4 million in future contracted revenues, demonstrating the continued demand for our services, and our recently announced Primech AI operating subsidiary has already generated strong commercial interest in its fully autonomous AI-powered toilet-cleaning...

Continue reading

Blue Foundry Bancorp Reports Second Quarter 2024 Results

RUTHERFORD, N.J., July 24, 2024 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $2.3 million, or $0.11 per diluted common share, for the three months ended June 30, 2024, compared to net loss of $2.8 million, or $0.13 per diluted common share, for the three months ended March 31, 2024, and a net loss of $1.8 million, or $0.08 per diluted common share, for the three months ended June 30, 2023. James D. Nesci, President and Chief Executive Officer, commented, “Deposit growth continued in the second quarter despite the highly competitive environment in our market area. We remain focused on growing the commercial loan portfolios and saw increases in commercial real estate and construction lending.” Mr. Nesci continued, “The Company...

Continue reading

Form 8.3 – [LOK’N STORE GROUP PLC – 23 07 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOK’N STORE GROUP PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e)   Date position...

Continue reading

Form 8.3 – [KEYWORDS STUDIOS PLC – 23 07 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e)   Date position...

Continue reading

Form 8.3 – [MATTIOLI WOODS PLC – 23 07 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MATTIOLI WOODS PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: MATTIOLI WOODS PLC AS AN ASSOCIATE...

Continue reading

R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives

Sets Final Bid Deadline of July 31, 2024 MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) — The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to submit fully-financed bids on July 31, 2024 in connection with its review process. No assurances can be given regarding the outcome or timing of the Special Committee’s review process. The Special Committee continues to evaluate all alternatives for R1, including continued execution of its strategic plan as a public company. R1 does...

Continue reading

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, August 7, 2024, to provide a corporate update and discuss details of the Company’s financial results for the quarter ended June 30, 2024. To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call. The live and archived webcast can be accessed under “Events & Presentations” in the Investor Relations section of the Company’s website at...

Continue reading

Fulcrum Therapeutics to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, July 31, 2024, at 8:00 a.m. ET

CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its second quarter 2024 financial results will be released on Wednesday, July 31, 2024, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.